Bettina Hartlieb

Title: Bettina Hartlieb: Innovator in Peptide Research

Introduction

Bettina Hartlieb is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of peptide research, particularly in the context of blood coagulation disorders. With a total of two patents to her name, her work has the potential to impact medical treatments and therapies.

Latest Patents

Bettina Hartlieb's latest patents focus on peptides and their methods of use. The inventions provide peptides that bind to and, optionally, inhibit Protein S. These peptides can be utilized to inhibit Protein S activity, enhance thrombin formation, increase blood clot formation, treat blood coagulation disorders, purify Protein S, and identify Protein S binding compounds. This innovative approach has the potential to revolutionize treatment options for patients with coagulation issues.

Career Highlights

Bettina Hartlieb is currently associated with Baxalta GmbH, where she continues her research and development in peptide technology. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Bettina collaborates with esteemed colleagues, including Michael Dockal and Thomas Polakowski. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Bettina Hartlieb's contributions to peptide research exemplify the impact of innovation in the medical field. Her patents and ongoing work at Baxalta GmbH highlight her dedication to improving health outcomes through scientific advancement.